Chimerix   Report issue

For profit Phase 1 Phase 3
Founded: Durham NC United States (2002)

Organization Overview

First Clinical Trial
2008
NCT00780182
First Marketed Drug
2021
brincidofovir (Tembexa)
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chimerix | CHIMERIX